Reversal of Benzodiazepine-Induced Myoclonus by Flumazenil in the Neonatal Intensive Care Unit
Neuropediatrics · 01.10.2024 · 55 (05) · 347-348
DOI: 10.1055/a-2338-5736 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropediatrics, erschienen am 01.10.2024. Verfasst von Gianluca D'Onofrio und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Flumazenil, Myoclonus, Benzodiazepines, Intensive Care Units, Neonatal. Die Arbeit nennt 3 Literaturangaben.
Themen: Neonatologie, Intensivpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
- Division of Pediatric Neurology, Department of Neurosciences, CHU Sainte-Justine, University of Montréal, Québec, Canada.
Zitieren
APA
D'Onofrio, G., & Major, P. (2024). Reversal of Benzodiazepine-Induced Myoclonus by Flumazenil in the Neonatal Intensive Care Unit. Neuropediatrics, 55(05), 347-348. https://doi.org/10.1055/a-2338-5736
Vancouver
D'Onofrio G, Major P. Reversal of Benzodiazepine-Induced Myoclonus by Flumazenil in the Neonatal Intensive Care Unit. Neuropediatrics. 2024;55(05):347-348. doi:10.1055/a-2338-5736
BibTeX
@article{DOnofrio2024,
author = {D'Onofrio, Gianluca and Major, Philippe},
title = {Reversal of Benzodiazepine-Induced Myoclonus by Flumazenil in the Neonatal Intensive Care Unit},
journal = {Neuropediatrics},
year = {2024},
volume = {55},
number = {05},
pages = {347--348},
doi = {10.1055/a-2338-5736}
}
EUVIMED